Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis

Colorectal cancer remains the third leading cause of cancer death worldwide, suggesting exploration of novel therapeutic avenues may be useful. In this study, therefore, we determined whether Tianfoshen oral liquid, a Chinese traditional medicine that has been used to treat non-small cell lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siliang, Wang, Hengbin, Lu, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362425/
https://www.ncbi.nlm.nih.gov/pubmed/28099904
http://dx.doi.org/10.18632/oncotarget.14675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362425/
https://www.ncbi.nlm.nih.gov/pubmed/28099904
http://dx.doi.org/10.18632/oncotarget.14675

Ejemplares similares